cytotoxicity of human cord blood natural killer cells is enhanced by recombinant interleukin-15
Authors
abstract
hematopoietic cord blood (cb) stem cell transplantation has more advantages to other cell sources because of lower graft versus host disease (gvhd). interleukin-15(il-15) is an immunoregulatory cytokine, known to enhance cytolytic function of cord natural killer (nk) cells. the aim of this study was to investigate the effect of il-15 on nk cytotoxicity simultaneously in different cell death stages. we compared the ability of il-15 to enhance the nk cytotoxicity of cb in comparison to adult blood mononuclear cells (mncs) against k562 target cells by co-staining with annexinv-fitc and propidium iodide after 3.5 h incubation at 37c and 5% co2 by using flow cytometric method. we also evaluated phenotypic changes after treatment by il-15 in both cell sources. our results indicated that cb samples had lower level of apoptosis, while necrosis was negligible; also by escalating effector: target (e: t), we got higher level of apoptosis and necrosis in peripheral blood (pb). nk activity of cord and adult mncs was enhanced by incubation with il-15 (10 ng/ml) for 72 h with significantly higher results of pb in comparison to cb (p taken together, these results indicated that nk cytotoxicity of cb mncs could be augmented by human recombinant (hr) il-15, but this activity did not reach to same level of pb counterparts. we established that cd25 expression on cb mncs could be increased with il-15, in 72-hour cultures, but to a lesser degree compared to that on corresponding adult pb mncs.
similar resources
Cytotoxicity of human cord blood natural killer cells is enhanced by recombinant interleukin-15.
Hematopoietic cord blood (CB) stem cell transplantation has more advantages to other cell sources because of lower Graft Versus Host Disease (GVHD). Interleukin-15(IL-15) is an immunoregulatory cytokine, known to enhance cytolytic function of cord Natural Killer (NK) cells. The aim of this study was to investigate the effect of IL-15 on NK cytotoxicity simultaneously in different cell death sta...
full textTHE CYTOTOXICITY PATHWAY OF NATURAL KILLER CELLS IN CORD BLOOD COMPARED TO P ERIPHERAL BLOOD
The cytotoxic activity of natural killer cells is usually tested by radioactive assay CSI Cr release assay), which detects the release of cytoplasmic contents after plasma membrane disintegration of dying cells. In contrast to this indirect evaluation of cytotoxicity, the assessment of cell damage by flow cytometry aims to provide a more exact characterization of the death pathway via detec...
full textthe cytotoxicity pathway of natural killer cells in cord blood compared to p eripheral blood
the cytotoxic activity of natural killer cells is usually tested by radioactive assay csi cr release assay), which detects the release of cytoplasmic contents after plasma membrane disintegration of dying cells. in contrast to this indirect evaluation of cytotoxicity, the assessment of cell damage by flow cytometry aims to provide a more exact characterization of the death pathway via detection...
full textInterleukin-18 synergism with interleukin-2 in cytotoxicity and NKG2D expression of human natural killer cells.
Natural killer (NK) cells play an important role in anti-tumor immunity. Interleukin (IL)-18 is an immunoregulatory cytokine that induces potent NK cell-dependent anti-tumor responses when administrated with other cytokines. In this study, we explored the effects of combining IL-18 and IL-2 on NK cytotoxicity as well as expression levels of the NK cell receptor NKG2D in vitro. Freshly isolated ...
full textTranspresentation of interleukin-15 by IL-15/IL-15Rα mRNA-engineered human dendritic cells boosts antitumoral natural killer cell activity.
In cancer immunotherapy, the use of dendritic cell (DC)-based vaccination strategies can improve overall survival, but until now durable clinical responses remain scarce. To date, DC vaccines are designed primarily to induce effective T-cell responses, ignoring the antitumor activity potential of natural killer (NK) cells. Aiming to further improve current DC vaccination outcome, we engineered ...
full textThe effects of recombinant interleukin 2-activated natural killer cells on autologous peripheral blood hematopoietic progenitors
In the present study, we demonstrate that resting and rIL-2-activated NK cells had no inhibitory effects on peripheral blood-derived hematopoietic progenitor (HP) cells. Peripheral blood HP cells were similar to bone marrow progenitors in phenotype and clonogenic colony formation capabilities. Peripheral blood HP cells could be cocultured in vitro with rIL-2-activated autologous NK cells for 3 ...
full textMy Resources
Save resource for easier access later
Journal title:
iranian journal of allergy, asthma and immunologyجلد ۹، شماره ۲، صفحات ۶۹-۷۷
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023